Your search matched 42 results
Is Your Mask Up to the Task? | Blog
Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”
Our Virtual Reality | Perspectives
Virtual collaboration isn’t the future of work – it's the wave of the present
Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.
COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.
COVID-19: Optimizing Promotions with HCP Preferences | Perspectives
Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.
COVID-19 has accelerated the rate at which we’re seeing change happening around us.
Part I of a Syneos Health Series on New Oncology Commercialization Strategies
Demonstrating Value in the Real World | Perspectives
Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.
It's Time for a Digital Reset | Perspectives
What should the evolution of your digital strategy look like through COVID-19 and beyond?
The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.
Virtual delivery requires you to rethink your content and approaches.
Leading Through Uncertainty Amidst the Global Pandemic | Perspectives
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.
How COVID-19 and 3 other barriers will transform healthcare over the next few years.
Meet Think Bank | Perspectives
Think Bank is an agile way to answer complex questions.
In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."
To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.
Recommendations for activities to inform and engage
Learn how to pivot and adapt your commercialization and communications tactics amid COVID-19 with insights from Rich Gorman and Leigh Householder at Syneos Health in this Xtalks webinar.
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
Achieving success in the current global context now hinges on “the virtual meeting” – the most important method for teams to stay connected, troubleshoot, and drive results.
Pivot Past the Pandemic | Perspectives
Life sciences commercialization in the COVID-19 era and beyond
As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.
The response to COVID-19 has brought into sharp focus the need for greater efficiencies in drug discovery and development.
With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.
Payer Priorities in a Pandemic | In The Media
What are payers focused on during the COVID-19 pandemic?
You might want to think twice about ignoring that call from a random number.
Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.
As we continue to navigate these unprecedented times, Syneos Health conducted two surveys during the months of March and May to help us track and understand the impact COVID-19 has had on physicians’ engagement with telemedicine platforms and field force teams.